nadunolimab
cantargia
['nadunolimab', 'pancreatic', 'cantargia']
cantargia presents new clinical data at aacr annual meeting 2023 strongly supporting nadunolimab development in pancreatic cancer. 
Computers are useless. They can only give you answers.